Remepy raises $36 million Series A as it prepares AI-driven Parkinson’s treatment for Phase III

August 12, 2026

More like this

August 12, 2026

Exclusive: Remepy raises $36M Series A for drug-software platform

Axios

August 12, 2026

Remepy Raises $36 Million Series A to Expand Its Hybrid Drug™ Pipeline Through Pharmaceutical Partnerships and Advance Phase III of Hybridopa™ for Parkinson's Disease

Press Release

Training app paired with levodopa eases Parkinson’s symptoms

Parkinson's News Today